Systematic review on the use of adalimumab in autoinmune. Efficacy and safety in 54 patients
Revisión sistemática del uso de adalimumab en enfermedades autoinmunes. Eficacia y seguridad en 54 pacientes
Leído
6636
Vecesse ha leído el artículo
3112
Total PDF
3524
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 2 | 5 | 7 |
| 2025 5 | 80 | 47 | 127 |
| 2025 4 | 62 | 38 | 100 |
| 2025 3 | 51 | 31 | 82 |
| 2025 2 | 68 | 37 | 105 |
| 2025 1 | 41 | 63 | 104 |
| 2024 12 | 27 | 47 | 74 |
| 2024 11 | 43 | 75 | 118 |
| 2024 10 | 20 | 43 | 63 |
| 2024 9 | 22 | 18 | 40 |
| 2024 8 | 36 | 38 | 74 |
| 2024 7 | 26 | 35 | 61 |
| 2024 6 | 32 | 29 | 61 |
| 2024 5 | 40 | 34 | 74 |
| 2024 4 | 29 | 17 | 46 |
| 2024 3 | 34 | 37 | 71 |
| 2024 2 | 19 | 26 | 45 |
| 2024 1 | 25 | 27 | 52 |
| 2023 12 | 30 | 31 | 61 |
| 2023 11 | 22 | 23 | 45 |
| 2023 10 | 34 | 50 | 84 |
| 2023 9 | 39 | 41 | 80 |
| 2023 8 | 25 | 12 | 37 |
| 2023 7 | 25 | 28 | 53 |
| 2023 6 | 29 | 24 | 53 |
| 2023 5 | 21 | 17 | 38 |
| 2023 4 | 28 | 10 | 38 |
| 2023 3 | 37 | 31 | 68 |
| 2023 2 | 26 | 31 | 57 |
| 2022 1 | 23 | 20 | 43 |
| 2022 12 | 24 | 30 | 54 |
| 2022 11 | 26 | 26 | 52 |
| 2022 10 | 29 | 35 | 64 |
| 2022 9 | 17 | 37 | 54 |
| 2022 8 | 22 | 44 | 66 |
| 2022 7 | 29 | 43 | 72 |
| 2022 6 | 24 | 36 | 60 |
| 2022 5 | 34 | 49 | 83 |
| 2022 4 | 40 | 51 | 91 |
| 2022 3 | 34 | 42 | 76 |
| 2022 2 | 54 | 45 | 99 |
| 2021 1 | 30 | 42 | 72 |
| 2021 12 | 27 | 39 | 66 |
| 2021 11 | 33 | 50 | 83 |
| 2021 10 | 43 | 57 | 100 |
| 2021 9 | 37 | 57 | 94 |
| 2021 8 | 32 | 51 | 83 |
| 2021 7 | 32 | 38 | 70 |
| 2021 6 | 26 | 58 | 84 |
| 2021 5 | 32 | 46 | 78 |
| 2021 4 | 69 | 58 | 127 |
| 2021 3 | 70 | 38 | 108 |
| 2021 2 | 76 | 29 | 105 |
| 2020 1 | 53 | 29 | 82 |
| 2020 12 | 33 | 22 | 55 |
| 2020 11 | 19 | 21 | 40 |
| 2020 10 | 18 | 16 | 34 |
| 2020 9 | 29 | 22 | 51 |
| 2020 8 | 19 | 12 | 31 |
| 2020 7 | 15 | 11 | 26 |
| 2020 6 | 29 | 16 | 45 |
| 2020 5 | 39 | 22 | 61 |
| 2020 4 | 30 | 18 | 48 |
| 2020 3 | 10 | 10 | 20 |
| 2020 2 | 1 | 0 | 1 |
| 2020 1 | 2 | 0 | 2 |
| 2019 9 | 4 | 0 | 4 |
| 2019 6 | 2 | 0 | 2 |
| 2019 3 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 5 | 1 | 6 |
| 2018 4 | 15 | 9 | 24 |
| 2018 3 | 11 | 12 | 23 |
| 2018 2 | 11 | 2 | 13 |
| 2018 1 | 8 | 9 | 17 |
| 2017 12 | 8 | 4 | 12 |
| 2017 11 | 5 | 17 | 22 |
| 2017 10 | 7 | 5 | 12 |
| 2017 9 | 13 | 6 | 19 |
| 2017 8 | 8 | 8 | 16 |
| 2017 7 | 8 | 11 | 19 |
| 2017 6 | 20 | 6 | 26 |
| 2017 5 | 16 | 15 | 31 |
| 2017 4 | 13 | 6 | 19 |
| 2017 3 | 8 | 21 | 29 |
| 2017 2 | 6 | 3 | 9 |
| 2016 1 | 10 | 4 | 14 |
| 2016 12 | 34 | 14 | 48 |
| 2016 11 | 14 | 2 | 16 |
| 2016 10 | 27 | 11 | 38 |
| 2016 9 | 28 | 8 | 36 |
| 2016 8 | 17 | 3 | 20 |
| 2016 7 | 16 | 5 | 21 |
| 2016 6 | 0 | 7 | 7 |
| 2016 4 | 0 | 12 | 12 |
| 2016 3 | 1 | 4 | 5 |
| 2015 1 | 3 | 16 | 19 |
| 2015 12 | 3 | 0 | 3 |
| 2015 11 | 0 | 5 | 5 |
| 2015 10 | 3 | 9 | 12 |
| 2015 9 | 2 | 0 | 2 |
| 2015 8 | 1 | 0 | 1 |
| 2015 7 | 19 | 5 | 24 |
| 2015 6 | 23 | 16 | 39 |
| 2015 5 | 61 | 23 | 84 |
| 2015 4 | 50 | 23 | 73 |
| 2015 3 | 33 | 17 | 50 |
| 2015 2 | 19 | 22 | 41 |
| 2015 1 | 11 | 30 | 41 |
| 2014 12 | 24 | 26 | 50 |
| 2014 11 | 14 | 25 | 39 |
| 2014 10 | 17 | 26 | 43 |
| 2014 9 | 20 | 18 | 38 |
| 2014 8 | 25 | 26 | 51 |
| 2014 7 | 38 | 20 | 58 |
| 2014 6 | 49 | 18 | 67 |
| 2014 5 | 24 | 29 | 53 |
| 2014 4 | 39 | 19 | 58 |
| 2014 3 | 40 | 33 | 73 |
| 2014 2 | 32 | 21 | 53 |
| 2014 1 | 31 | 23 | 54 |
| 2013 12 | 25 | 14 | 39 |
| 2013 11 | 29 | 11 | 40 |
| 2013 10 | 32 | 22 | 54 |
| 2013 9 | 34 | 18 | 52 |
| 2013 8 | 22 | 13 | 35 |
| 2013 7 | 44 | 31 | 75 |
| 2013 6 | 32 | 22 | 54 |
| 2013 5 | 35 | 20 | 55 |
| 2013 4 | 25 | 28 | 53 |
| 2013 3 | 21 | 22 | 43 |
| 2013 2 | 20 | 26 | 46 |
| 2013 1 | 15 | 15 | 30 |
| 2012 12 | 23 | 13 | 36 |
| 2012 11 | 15 | 16 | 31 |
| 2012 10 | 9 | 17 | 26 |
| 2012 9 | 12 | 4 | 16 |
| 2012 7 | 1 | 0 | 1 |
| 2012 6 | 1 | 0 | 1 |
| 2012 5 | 3 | 0 | 3 |
| 2012 4 | 4 | 0 | 4 |
| 2012 3 | 2 | 0 | 2 |
| 2012 2 | 2 | 0 | 2 |
| 2011 1 | 3 | 0 | 3 |
| 2011 12 | 3 | 0 | 3 |
| 2011 10 | 4 | 0 | 4 |
| 2011 8 | 2 | 0 | 2 |
| 2011 7 | 1 | 0 | 1 |
| 2011 6 | 2 | 0 | 2 |
| 2011 5 | 3 | 0 | 3 |
| 2011 4 | 4 | 0 | 4 |
| 2011 3 | 5 | 0 | 5 |
| 2011 2 | 2 | 0 | 2 |
| 2010 1 | 9 | 0 | 9 |
| 2010 12 | 9 | 0 | 9 |
| 2010 11 | 19 | 0 | 19 |
| 2010 10 | 15 | 0 | 15 |
| 2010 9 | 5 | 0 | 5 |
Mostrar todo
